Abstract
purpose. To evaluate the physiological characteristics of the macula in patients with Vogt-Koyanagi-Harada disease during the convalescent stage with specific reference to the kinetics of foveal cone photopigment regeneration.
methods. Six eyes of three patients at the convalescent stage of Vogt-Koyanagi-Harada disease were studied. All the eyes had best corrected visual acuity of 1.0 or better and had had no recurrence of inflammation for at least 12 months after the last episode. Foveal cone densitometry (FCD), focal macular electroretinograms, color vision tests, two-color perimetry, and optical coherence tomography (OCT) were performed.
results. No regeneration of cone photopigments was detected within the 7-minute testing time by FCD in all eyes at the first examination after the last episode. However, the other functional tests were normal, and the OCT-determined macular morphology was also normal. The regeneration kinetics of the foveal cone photopigment improved in three of six eyes at 36, 37, and 19 months after the last episode, whereas the other three remained delayed at 18, 18, and 49 months.
conclusions. These findings suggest that a disorder of the foveal cone photopigment regeneration, and its recovery, requires a significantly longer time than that of other macular functions in some patients with Vogt-Koyanagi-Harada disease.
Vogt-Koyanagi-Harada disease is a systemic inflammatory disorder that results from an autoimmune reaction against melanocytes.
1 2 In most cases of Vogt-Koyanagi-Harada disease, good vision is regained after the inflammation subsides after appropriate treatment, regardless of the severity of the retinal pigment epithelial (RPE) changes.
3 4 5 Electrophysiological studies have demonstrated that the dysfunction of the outer retinal layer is severe in Vogt-Koyanagi-Harada disease, whereas dysfunction of the inner retinal layer is mild and reversible.
6 7 8
Patients with Vogt-Koyanagi-Harada disease have high retinal detachments involving the macula, resulting in severe visual loss in the acute stage. Unfortunately, there are no studies on the recovery of macular function during the convalescent stage of Vogt-Koyanagi-Harada disease.
Foveal cone densitometry (FCD) is a noninvasive technique for evaluating the kinetics of photopigment regeneration which is related to the function of photoreceptors and retinal pigment epithelium.
The purpose of this study was to evaluate macular function of patients with Vogt-Koyanagi-Harada disease at the convalescent stage. FCD, focal macular electroretinograms (fmERGs), two-color perimetry, and color vision tests were performed on the patients. In addition, optical coherence tomography (OCT) was used to determine the morphology of the macular area.
Six eyes of three patients with Vogt-Koyanagi-Harada disease in the convalescent stage were studied. All the eyes had best corrected visual acuity of 1.0 or better and had had no recurrence of inflammation for at least 12 months after the most recent episode. Vogt-Koyanagi-Harada disease had been diagnosed by the clinical findings: anterior segment inflammation, serous retinal detachment, optic disc edema, and the presence of multiple RPE leakage in fluorescein angiography. In addition, human leukocyte antigen (HLA) DR53, DR4, B54, and DQ4 were positive in all cases, and the number of monocytes in the cerebrospinal fluid was increased in patients 2 and 3. The fundus of patients 1 and 3 had the classic sunset glow appearance at the initial visit and at the 3-week follow-up examination. Such a characteristic appearance was not found in patient 2 throughout the follow-up period. Although the revised diagnostic criteria for Vogt-Koyanagi-Harada disease
9 had not been published at the time patients received diagnosis, a review of the charts of these patients showed that they met the revised diagnostic criteria.
This research was conducted in accordance with the institutional guidelines of Nagoya University and conformed to the tenets of the World Medical Association Declaration of Helsinki. After a complete explanation of the purpose of this study and the procedures to be performed, an informed consent was obtained from each patient.
The pupils were dilated with 0.5% tropicamide and 0.5% phenylephrine before FCD, fmERGs, two-color perimetry, and OCT.
Patient 1.
A 65-year-old Japanese man reported blurred vision and was referred to the Nagoya University Hospital because of a residual inflammation despite oral and topical steroids. At the initial examination, his visual acuity was 0.5 in the right eye and 1.0 in the left eye. The anterior segment inflammation was treated with systemic corticosteroids that were tapered over 2 years. His visual acuity improved to 1.0 in both eyes within 2 weeks, and no recurrence was observed. FCD was performed at 24, 36, 42, and 49 months after the last episode.
Patient 2.
Patient 3.
The fmERGs, color vision, and two-color perimetry improved to the normal range in patients with Vogt-Koyanagi-Harada disease after the inflammation subsided. However, our findings demonstrated that the recovery of the photopigment regeneration kinetics takes much longer than the recovery of other macular functions. Thus, the photopigment regeneration kinetics were impaired even when the static functions of the visual pathway, obtained by color vision tests and two-color perimetry, had recovered. These discrepancies in visual functions in the macula in eyes with Vogt-Koyanagi-Harada disease at the convalescent stage have not been reported.
Vogt-Koyanagi-Harada disease is characterized by extensive retinal detachment and inflammation involving the retina and choroid. The question arises whether the regeneration kinetics abnormality simply reflects the aftereffects of the severity of the retinal detachment caused by Vogt-Koyanagi-Harada disease. Liem et al.
21 reported that there was a gradual recovery of the density of foveal cone photopigments in nine eyes of nine patients within 14 months after rhegmatogenous retinal detachment surgery by foveal cone densitometry. In our cases, the kinetics of foveal cone photopigments improved in only three of six eyes, and the recovery did not begin until at least 15 months after the resolution of the retinal detachment, despite good visual acuity. In addition, OCT showed no retinal detachment or macular edema in our cases. Our data indicate that the delayed recovery of the foveal cone photopigment kinetics in Vogt-Koyanagi-Harada disease was not only due to the former retinal detachment but also to the inflammatory impairment in the retina and RPE.
It has been reported that the hyperosmolarity response of the ocular standing potential is suppressed at the convalescent stage of Vogt-Koyanagi-Harada disease.
7 Pathologically, abnormalities of choroid and RPE, including marked loss of choroidal melanocytes, scattered infiltration of lymphocytes in the choroid, and destruction or hyperplasia of RPE have been reported in eyes with Vogt-Koyanagi-Harada disease.
22 23 24 In addition, abnormalities of the choroid and RPE have been detected by indocyanine green video angiography in eyes with Vogt-Koyanagi-Harada disease in the convalescent stage.
25 26 Therefore, pathologic and functional disorders of the RPE may contribute to the longstanding abnormality in the visual photopigment kinetics. In addition, the recovery of cone dark adaptation was reported to be slow in severely affected patients at the convalescent stage,
27 which supports the abnormal function of cone system in our patients.
In patient 2, a recovery of cone photopigment kinetics was observed earlier than in the other two cases. His visual acuity before treatment was better, and he was much younger than the others. In addition, his fundus did not show the sunset glow appearance. These factors may have led to the relatively rapid recovery of his outer retinal function. The recovery of cone function in Vogt-Koyanagi-Harada disease has been reported to be different and dependent on the severity of the inflammation.
27
We are observing these patients and will collect similar data from any new patients with Vogt-Koyanagi-Harada disease as they become available. Data from more cases of different severity and longer follow-up periods will be helpful in determining the convalescent course of patients with Vogt-Koyanagi-Harada disease.
Supported by Grant-in Aid 13307048 (YM) from the Ministry of Education, Science, Sports and Culture, Japan.
Submitted for publication April 15, 2003; revised September 5, 2003; accepted September 8, 2003.
Disclosure:
Y. Okamoto, None;
Y. Miyake, None;
N. Horio, None;
H. Takakuwa, None;
E. Yamamoto, None;
H. Terasaki, None
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be marked “
advertisement” in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Corresponding author: Yoko Okamoto, Department of Ophthalmology, Nagoya University School of Medicine, 65 Tsuruma-cho, Showa-ku, Nagoya, 466-8550, Japan;
[email protected].
Table 1. Results of Color Vision Test at the First Examination after the Last Episode
Table 1. Results of Color Vision Test at the First Examination after the Last Episode
Patient/Age (y) | Eye | Anomaloscope Red-Green Scale (Yellow Scale) | 100-Hue Test Error Score | SPP 2 |
1/65 | R | 33–40 (15) | 152 | BY1 fail |
| L | 35–40 (15) | 108 | BY1 fail |
2/23 | R | 39 (16) | 72 | Pass |
| L | 38 (16) | 80 | Pass |
3/45 | R | 37–40 (15, 16) | 76 | Pass |
| L | 35–40 (15) (17) | 80 | Pass |
Table 2. Foveal Cone Densitometry in Eyes after the Last Episode
Table 2. Foveal Cone Densitometry in Eyes after the Last Episode
Patient/Eye | Period after the Last Episode (mo) | Foveal Cone Densitometry | |
| | Density Difference (log) | Time Constant (s) |
1/right | 24 | 0.00 | NM |
| 36 | 0.21 | 169.9 |
| 49 | 0.28 | 158.3 |
2/right | 15 | 0.00 | NM |
| 19 | 0.00 | NM |
| 37 | 0.41 | 161.5 |
2/left | 15 | 0.00 | NM |
| 19 | 0.29 | 145.5 |
| 37 | 0.40 | 108.9 |
Read RW, Rao NA, Cunningham ET. Vogt-Koyanagi-Harada disease. Curr Opin Ophthalmol
. 2000;11:437–442.
[CrossRef] [PubMed]Tagawa Y. Lymphocyte-mediated cytotoxicity against melanocyte antigens in Vogt-Koyanagi-Harada disease. Jpn J Ophthalmol. 1978;22:36–41.
Rubsamen PE, Gass JD. Vogt-Koyanagi-Harada syndrome: clinical course, therapy, and long-term visual outcome. Arch Ophthalmol
. 1991;109:682–687.
[CrossRef] [PubMed]Sugiura S. Vogt-Koyanagi-Harada disease. Jpn J Ophthalmol. 1978;22:9–35.
Chan CC, Palestine AG, Kuwabara T, Nussenblatt RB. Immunopathologic study of Vogt-Koyanagi-Harada syndrome. Am J Ophthalmol
. 1988;105:607–611.
[CrossRef] [PubMed]Jacobson JH, Popkin A, Hirose T. The electroretinogram in Harada’s disease. Am J Ophthalmol
. 1967;64:1152–1154.
[CrossRef] [PubMed]Madachi-Yamamoto S, Kawasaki K, Yonemura D. Retinal pigment epithelium disorder in Vogt-Koyanagi-Harada disease revealed by hyperosmolarity response of ocular standing potential. Jpn J Ophthalmol
. 1984;28:362–369.
[PubMed]Nagaya T. Use of the electro-oculogram for diagnosing and following the development of Harada’s disease. Am J Ophthalmol
. 1972;74:99–109.
[CrossRef] [PubMed]Read RW, Holland GN, Rao NA, et al. Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature. Am J Ophthalmol
. 2001;131:647–652.
[CrossRef] [PubMed]Miyake Y. Layer-by-layer analysis of macular diseases with objectively measured visual functions. Jpn J Ophthalmol
. 1990;34:225–238.
[PubMed]Horio N, Miyake Y, Horiguchi M. Kinetics of foveal cone photopigment in myopia without chorioretinal degeneration. Jpn J Ophthalmol
. 1999;43:44–47.
[CrossRef] [PubMed]Miyake Y. Studies of local macular ERG (in Japanese). Nippon Ganka Gakkai Zasshi
. 1988;92:1419–1449.
[PubMed]Miyake Y, Miyake K, Shiroyama N. Classification of aphakic cystoid macular edema with focal macular electroretinograms. Am J Ophthalmol
. 1993;116:576–583.
[CrossRef] [PubMed]Miyake Y, Shiroyama N, Ota I, Horiguchi M. Oscillatory potentials in electroretinograms of the human macular region. Invest Ophthalmol Vis Sci
. 1988;29:1631–1635.
[PubMed]Jacobson SG, Voigt WJ, Parel JM, et al. Automated light- and dark-adapted perimetry for evaluating retinitis pigmentosa. Ophthalmology
. 1986;93:1604–1611.
[CrossRef] [PubMed]Miyake Y, Horiguchi M, Tomita N, et al. Occult macular dystrophy. Am J Ophthalmol
. 1996;122:644–653.
[CrossRef] [PubMed]Nomura R, Kondo M, Tanikawa A, Yamamoto N, Terasaki H, Miyake Y. Unilateral cone dysfunction with bull’s eye maculopathy. Ophthalmology
. 2001;108:49–53.
[CrossRef] [PubMed]Huang D, Swanson EA, Lin CP, et al. Optical coherence tomography. Science
. 1991;254:1178–1181.
[CrossRef] [PubMed]Horio N, Kachi S, Hori K, et al. Progressive change of optical coherence tomography scans in retinal degeneration slow mice. Arch Ophthalmol
. 2001;119:1329–1332.
[CrossRef] [PubMed]Terasaki H, Miyake Y. Japanese family with blue cone monochromatism. Jpn J Ophthalmol
. 1992;36:132–141.
[PubMed]Liem AT, Keunen JE, van Meel GJ, van Norren D. Serial foveal densitometry and visual function after retinal detachment surgery with macular involvement. Ophthalmology
. 1994;101:1945–1952.
[CrossRef] [PubMed]Lubin JR, Ni C, Albert DM. Clinicopathological study of the Vogt-Koyanagi-Harada syndrome. Int Ophthalmol Clin. 1982;22:141–156.
Perry HD, Font RL. Clinical and histopathologic observations in severe Vogt-Koyanagi-Harada syndrome. Am J Ophthalmol
. 1977;83:242–254.
[CrossRef] [PubMed]Inomata H, Sakamoto T. Immunohistochemical studies of Vogt-Koyanagi-Harada disease with sunset sky fundus. Curr Eye Res
. 1990;9(suppl)35–40.
[CrossRef] [PubMed]Okada AA, Mizusawa T, Sakai J, Usui M. Videofunduscopy and videoangiography using the scanning laser ophthalmoscope in Vogt-Koyanagi-Harada syndrome. Br J Ophthalmol
. 1998;82:1175–1181.
[CrossRef] [PubMed]Oshima Y, Harino S, Hara Y, Tano Y. Indocyanine green angiographic findings in Vogt-Koyanagi-Harada disease. Am J Ophthalmol
. 1996;122:58–66.
[CrossRef] [PubMed]Yokota A, Wake T. Cone dark adaptation in Harada’s disease (in Japanese). Nippon Ganka Gakkai Zasshi
. 1986;90:1624–1633.
[PubMed]